|
COCP | Cocrystal Pharma, Inc. |
|
|
COCP | Cocrystal Pharma, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.48 |
| Leverage | 37.30% |
| Market Cap | $ 11.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -12.5m |
| Margin | -7810.01% |
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.